|
2WOK
Clavulanic acid biosynthesis oligopeptide binding protein 2 complexed with bradykinin
提交 2009-07-26
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
381–389(9 aa)
|
未记录
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
pH 8;pH 8
|
分辨率 1.70 Å
R-free 0.223
|
|
4ASQ
Crystal structure of ANCE in complex with Bradykinin
提交 2012-05-02
|
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 P
381–389(9 aa)
|
未记录
|
ZN ZINC ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
FLC CITRATE ANION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
pH 7.5;100 MM HEPES 1.3 M SODIUM CITRATE, pH 7.5
|
分辨率 1.99 Å
R-free 0.200
|
|
4ASR
Crystal structure of ANCE in complex with Thr6-Bradykinin
提交 2012-05-02
|
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 P
381–389(9 aa)
|
突变:YES
|
ZN ZINC ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
FLC CITRATE ANION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
pH 7.5;100 MM HEPES 1.3 M SODIUM CITRATE, pH 7.5
|
分辨率 1.90 Å
R-free 0.200
|
|
4ECB
Chimeric GST Containing Inserts of Kininogen Peptides
提交 2012-03-26
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
信息不足
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
498–507(10 aa)
片段:unp residues 1-49, kinonogen 498-507, 50-228
链 B
498–507(10 aa)
片段:unp residues 1-49, kinonogen 498-507, 50-228
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;100 mM HEPES, 200 mM KCl, 35% Pentaerythritol propoxylate, 0.1 M ATP solution, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
分辨率 2.20 Å
R-free 0.248
|
|
4ECC
Chimeric GST Containing Inserts of Kininogen Peptides
提交 2012-03-26
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
信息不足
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
498–510(13 aa)
片段:unp residues 1-49, kinonogen 498-510, 50-228
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;(1)0.2 M Ammonium Sulfate, 0.1 M Hepes, 25% PEG 3350 (2)0.2 M Lithium Sulfate, 25% PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
分辨率 2.20 Å
R-free 0.269
|
|
6F27
NMR solution structure of non-bound [des-Arg10]-kallidin (DAKD)
提交 2017-11-23
|
构建体不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
380–388(9 aa)
|
未记录
|
未记录非水小分子
|
SOLUTION NMR
NMR测量条件
pH 5.6;295 K;离子强度(mmCIF原始值)111;压力 ambient
NMR样品组成
3 mM DAKD, 50 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
分辨率未提供
|
|
6F3W
Backbone structure of free bradykinin (BK) in DDM/CHS detergent micelle determined by MAS SSNMR
提交 2017-11-29
|
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
381–389(9 aa)
|
未记录
|
未记录非水小分子
|
SOLID-STATE NMR
NMR测量条件
pH 7.4;200 K;离子强度(mmCIF原始值)125;压力 1
NMR样品组成
0.36 ug/uL [U-13C, 15N]-F8R9 Bradykinin (BK), 50 mM not labeled HEPES, 100 mM not labeled NaCl, 2 mM not labeled EDTA, 4 % w/v not labeled DDM, 100% H2O | 100% H2O
NMR样品组成
0.36 ug/uL [U-13C, 15N]-P2P3G4F5S6P7F8 Bradykinin (BK), 50 mM not labeled HEPES, 100 mM not labeled NaCl, 2 mM not labeled EDTA, 4 % w/v not labeled DDM, 100% H2O | 100% H2O
|
分辨率未提供
|
|
6F3X
Backbone structure of Des-Arg10-Kallidin (DAKD) peptide in frozen DDM/CHS detergent micelle solution determined by DNP-enhanced MAS SSNMR
提交 2017-11-29
|
构建体不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
380–388(9 aa)
|
未记录
|
未记录非水小分子
|
SOLID-STATE NMR
NMR测量条件
pH 7.6;110 K;离子强度(mmCIF原始值)175;压力 1
NMR样品组成
300 uM [U-13C; U-15N] K1 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS, 10% H2O/ 40%D2O/ 50% d8-glycerol | 10% H2O/ 40%D2O/ 50% d8-glycerol
NMR样品组成
300 uM [U-13C; U-15N] R2S7 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS, 10% H2O/ 40%D2O/ 50% d8-glycerol | 10% H2O/ 40%D2O/ 50% d8-glycerol
NMR样品组成
300 uM [U-13C; U-15N] P3 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS, 10% H2O/ 40%D2O/ 50% d8-glycerol | 10% H2O/ 40%D2O/ 50% d8-glycerol
NMR样品组成
300 uM [U-13C; U-15N] P4 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS, 10% H2O/ 40%D2O/ 50% d8-glycerol | 10% H2O/ 40%D2O/ 50% d8-glycerol
NMR样品组成
300 uM [U-13C; U-15N] G5F6 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS, 10% H2O/ 40%D2O/ 50% d8-glycerol | 10% H2O/ 40%D2O/ 50% d8-glycerol
NMR样品组成
300 uM [U-13C; U-15N] S7P9 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS, 10% H2O/ 40%D2O/ 50% d8-glycerol | 10% H2O/ 40%D2O/ 50% d8-glycerol
|
分辨率未提供
|
|
6F3Y
Backbone structure of Des-Arg10-Kallidin (DAKD) peptide bound to human Bradykinin 1 Receptor (B1R) determined by DNP-enhanced MAS SSNMR
提交 2017-11-29
|
构建体不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
380–388(9 aa)
|
未记录
|
未记录非水小分子
|
SOLID-STATE NMR
NMR测量条件
pH 7.6;110 K;离子强度(mmCIF原始值)175;压力 1
NMR样品组成
312.5 uM [U-13C; U-15N] K1 Des-Arg10-Kallidin (DAKD), 312.5 uM not labeled human B1R, 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS, 10% H2O/ 40%D2O/ 50% d8-glycerol | 10% H2O/ 40%D2O/ 50% d8-glycerol
NMR样品组成
312.5 uM [U-13C; U-15N] R2S7 Des-Arg10-Kallidin (DAKD), 312.5 uM not labeled human B1R, 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS, 10% H2O/ 40%D2O/ 50% d8-glycerol | 10% H2O/ 40%D2O/ 50% d8-glycerol
NMR样品组成
312.5 uM [U-13C; U-15N] P3 Des-Arg10-Kallidin (DAKD), 312.5 uM not labeled human B1R, 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS, 10% H2O/ 40%D2O/ 50% d8-glycerol | 10% H2O/ 40%D2O/ 50% d8-glycerol
NMR样品组成
312.5 uM [U-13C; U-15N] P4 Des-Arg10-Kallidin (DAKD), 312.5 uM not labeled human B1R, 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS, 10% H2O/ 40%D2O/ 50% d8-glycerol | 10% H2O/ 40%D2O/ 50% d8-glycerol
NMR样品组成
312.5 uM [U-13C; U-15N] G5F6 Des-Arg10-Kallidin (DAKD), 312.5 uM not labeled human B1R, 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS, 10% H2O/ 40%D2O/ 50% d8-glycerol | 10% H2O/ 40%D2O/ 50% d8-glycerol
NMR样品组成
312.5 uM [U-13C; U-15N] S7P9 Des-Arg10-Kallidin (DAKD), 312.5 uM not labeled human B1R, 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS, 10% H2O/ 40%D2O/ 50% d8-glycerol | 10% H2O/ 40%D2O/ 50% d8-glycerol
|
分辨率未提供
|
|
7QOT
Factor XI and Plasma Kallikrein apple domain structures reveals different kininogen bound complexes
提交 2021-12-28
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 C
583–613(31 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray结晶条件
EVAPORATION;288 K;0.1M Tris pH8, 1.5M AMMONIUM SULFATE
|
分辨率 3.24 Å
R-free 0.284
|
|
7QOT
Factor XI and Plasma Kallikrein apple domain structures reveals different kininogen bound complexes
提交 2021-12-28
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 D
583–613(31 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray结晶条件
EVAPORATION;288 K;0.1M Tris pH8, 1.5M AMMONIUM SULFATE
|
分辨率 3.24 Å
R-free 0.284
|
|
7QOX
Factor XI and Plasma Kallikrein apple domain structures reveals different kininogen bound complexes
提交 2021-12-29
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 C
582–609(28 aa)
|
未记录
|
GOL GLYCEROL × 1
PEG DI(HYDROXYETHYL)ETHER × 3
PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1
PG4 TETRAETHYLENE GLYCOL × 2
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
EVAPORATION;288 K;Morpheus screen H9 condition:
0.1M amino acids, 0.1M buffer system 3 pH8.5, 30% precipitant mix 1.
|
分辨率 2.32 Å
R-free 0.253
|
|
7QOX
Factor XI and Plasma Kallikrein apple domain structures reveals different kininogen bound complexes
提交 2021-12-29
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 D
582–609(28 aa)
|
未记录
|
GOL GLYCEROL × 5
PEG DI(HYDROXYETHYL)ETHER × 2
PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
PG6 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
EVAPORATION;288 K;Morpheus screen H9 condition:
0.1M amino acids, 0.1M buffer system 3 pH8.5, 30% precipitant mix 1.
|
分辨率 2.32 Å
R-free 0.253
|